The role of health-related quality-of-life data in pharmacy benefit decisions

P and T

Volumn 27, Issue 1, 2002, Pages

  Delate, Thomas ^a   Ernst, Frank R ^a   Coons, Stephen Joel ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HOSPITAL PHARMACY; MEDICAL DECISION MAKING; PHARMACIST; QUALITY OF LIFE;

EID: 0036156711     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Reporting on quality of life in randomised controlled trials: Bibliographic study
2. The importance of health-related quality of life data in determining the value of drug therapy
3. Health-related quality of life: An overview
4. Incorporating quality of life data into managed care formulary decisions: Case study with salmeterol
5. References for health-related quality-of-life claims in prescription drug advertisements
6. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
7. Applying pharmacoeconomic and quality of life measures to the formulary management process
8. Managed care pharmacy: Socioeconomic assessments and drug adoption decisions
9. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
10. Guidelines for assessing outcomes of antihypertensive treatment
11. Formulary decisions and health economics
12. Quality of life as an outcome measure for epilepsy clinical trials
13. Formulary influences
14. Current formulary decision-making strategies and new factors influencing the process
15. Role of pharmacoeconomics in drug benefit decision-making: Results of a survey
16. Application of health-related quality of life to hospital pharmacy practice